Patents Assigned to ALKEMYS
  • Anti-TREM-1 antibodies
    Patent number: 12780919
    Abstract: Novel anti-TREM-1 (Triggering Receptor Expressed on Myeloid cells-1) antibodies and antigen-binding fragments thereof. Also, fusion proteins that include these anti-TREM-1 antibodies and antigen-binding fragments thereof, as well as the therapeutic uses thereof for treating of a disease, such as an inflammatory or autoimmune disease, a cardiovascular disease, a cancer, or an infectious disease.
    Type: Grant
    Filed: June 2, 2022
    Date of Patent: November 3, 2026
    Assignee: ALKEMYS
    Inventors: Marc Derive, Jean-Jacques Garaud, Amir Boufenzer, Marine Maillefer, Julie Voison-Christophe, Kévin Carrasco